Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Capital Leases (2020 - 2025)

Historic Capital Leases for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q3 2025 value amounting to $30.4 million.

  • Maravai Lifesciences Holdings' Capital Leases fell 293.68% to $30.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.4 million, marking a year-over-year decrease of 293.68%. This contributed to the annual value of $31.1 million for FY2024, which is 247.99% down from last year.
  • Maravai Lifesciences Holdings' Capital Leases amounted to $30.4 million in Q3 2025, which was down 293.68% from $30.7 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' Capital Leases' 5-year high stood at $55.9 million during Q1 2021, with a 5-year trough of $16.6 million in Q1 2023.
  • For the 4-year period, Maravai Lifesciences Holdings' Capital Leases averaged around $35.5 million, with its median value being $31.6 million (2024).
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Capital Leases skyrocketed by 9140.56% in 2024 and then tumbled by 293.68% in 2025.
  • Maravai Lifesciences Holdings' Capital Leases (Quarter) stood at $55.3 million in 2021, then crashed by 42.35% to $31.9 million in 2023, then dropped by 2.48% to $31.1 million in 2024, then dropped by 2.25% to $30.4 million in 2025.
  • Its last three reported values are $30.4 million in Q3 2025, $30.7 million for Q2 2025, and $30.9 million during Q1 2025.